Adverum Biotechnologies, Inc.
ADVMDelisted Dec 9, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501756
Adverum Biotechnologies, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 10, 2025; 50 institutions reported holding it in 13F filings for Q3 2025, worth $63.8M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Adverum Biotechnologies, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 55 | 58 | +3 |
| Shares | 62.7M | 65.7M | +2.93M (+4.7%) |
| Value | $45.0M | $104.4M | +$59.4M (+132.0%) |
New holders (8)
Institutions that held Adverum Biotechnologies, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| VR Adviser, LLC | 3,886,246 | $6.18M | 0.99% |
| Acuitas Investments, LLC | 613,328 | $975.2K | 0.57% |
| Soleus Capital Management, L.P. | 320,000 | $508.8K | 0.06% |
| Bridgeway Capital Management, LLC | 50,000 | $79.5K | 0.00% |
| XTX Topco Ltd | 16,332 | $26.0K | 0.00% |
| Ausdal Financial Partners, Inc. | 10,000 | $15.9K | 0.00% |
| Lazard Asset Management LLC | 10,059 | $15.0K | 0.00% |
| Rhumbline Advisers | 2,937 | $4.67K | 0.00% |
Sold out (5)
Institutions that held Adverum Biotechnologies, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Assenagon Asset Management S.A. | 840,651 | $603.1K |
| CM Management, LLC | 375,000 | $269.0K |
| Virtu Financial LLC | 14,498 | $10.0K |
| Victory Capital Management Inc | 10,166 | $7.29K |
| Citadel Advisors LLC | 4,221 | $3.03K |